Literature DB >> 14966090

An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies.

Marisa A Navo1, Julie Phan, Christy Vaughan, J Lynn Palmer, Laura Michaud, Kellie L Jones, Diane C Bodurka, Karen Basen-Engquist, Gabriel N Hortobagyi, John J Kavanagh, Judith A Smith.   

Abstract

PURPOSE: To describe and assess the current utilization of complementary and alternative medicines (CAMs) in women with a diagnosis of either gynecologic or breast cancer and evaluate their reasons for use. PATIENTS AND METHODS: This study included 250 female patients from the Multidisciplinary Breast Center and 250 patients from the Gynecologic Oncology Center of The University of Texas M.D. Anderson Cancer Center (Houston, TX). Patients were selected by having an odd-numbered medical record number, and they were contacted before their clinic visit. The goals of the study were explained, and verbal consent was obtained. Patients who agreed to participate were asked to bring a written list and the medication bottles of all over-the-counter prescriptions and CAMs with them to clinic. In clinic, the investigator obtained a written informed consent and administered the survey. All patients and surveys were assessable.
RESULTS: The most frequently used herbal products and megavitamins/minerals were identified from the patient medication histories. Overall, we found the proportion of patients using CAM to be 48% (95% CI, 44% to 53%; 241 of 500 patients). CAM use was related to patients' educational status: 62% had postgraduate degrees, 50% had college degrees, 56% had some college, and 33% had a high school education or less. Also, among patients using CAMs, only 53.5% had spoken to a healthcare provider regarding CAM therapy.
CONCLUSION: The use of CAM is common among women with cancer. Studies need to be conducted to establish if there are any potential drug interactions and/or therapeutic benefit of CAM products. Moreover, there is a need to educate patients and healthcare providers on appropriate and safe use of CAM products.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966090     DOI: 10.1200/JCO.2004.04.162

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  46 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

2.  The use of healing touch in integrative oncology.

Authors:  Laura K Hart; Mildred I Freel; Pam J Haylock; Susan K Lutgendorf
Journal:  Clin J Oncol Nurs       Date:  2011-10       Impact factor: 1.027

3.  Cancer and complementary medicine: an international perspective.

Authors:  Vinjar Fønnebø; Marja Verhoef; Charlotte Paterson
Journal:  Support Care Cancer       Date:  2007-07-03       Impact factor: 3.603

4.  Prevalence of complementary and alternative medicine use in cancer patients during treatment.

Authors:  Jennifer S Yates; Karen M Mustian; Gary R Morrow; Leslie J Gillies; Devi Padmanaban; James N Atkins; Brian Issell; Jeffrey J Kirshner; Lauren K Colman
Journal:  Support Care Cancer       Date:  2005-02-15       Impact factor: 3.603

5.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

6.  Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting.

Authors:  Eran Ben-Arye; Dikla Kruger; Noah Samuels; Lital Keinan-Boker; Tamar Shalom; Elad Schiff
Journal:  Support Care Cancer       Date:  2014-03       Impact factor: 3.603

7.  Integration of complementary medicine in supportive cancer care: survey of health-care providers' perspectives from 16 countries in the Middle East.

Authors:  Eran Ben-Arye; Elad Schiff; Kamer Mutafoglu; Suha Omran; Ramzi Hajjar; Haris Charalambous; Tahani Dweikat; Ibtisam Ghrayeb; Gil Bar Sela; Ibrahim Turker; Azza Hassan; Esmat Hassan; Ariela Popper-Giveon; Bashar Saad; Omar Nimri; Rejin Kebudi; Jamal Dagash; Michael Silbermann
Journal:  Support Care Cancer       Date:  2015-01-24       Impact factor: 3.603

8.  Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics.

Authors:  Leanna J Standish; Erin Sweet; Eleonora Naydis; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2012-06-27       Impact factor: 3.279

Review 9.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

10.  Nutrient Composition and Anti-inflammatory Potential of a Prescribed Macrobiotic Diet.

Authors:  Brook E Harmon; Mollie Carter; Thomas G Hurley; Nitin Shivappa; Jane Teas; James R Hébert
Journal:  Nutr Cancer       Date:  2015-07-25       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.